The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor β3

por Weng, Lin, Funderburgh, James L., Khandaker, Irona, Geary, Moira L., Yang, Tianbing, Basu, Rohan, Funderburgh, Martha L., Du, Yiqin, Yam, Gary Hin-Fai
Publicado 2020

Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p – A robust cell selection tool for stem cell therapy of corneal scarring

por Yam, Gary Hin-Fai, Yang, Tianbing, Geary, Moira L, Santra, Mithun, Funderburgh, Martha, Rubin, Elizabeth, Du, Yiqin, Sahel, Jose A, Jhanji, Vishal, Funderburgh, James L
Publicado 2022

Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle‐Mediated Delivery of miRNA

por Shojaati, Golnar, Khandaker, Irona, Funderburgh, Martha L., Mann, Mary M., Basu, Rohan, Stolz, Donna B., Geary, Moira L., Dos Santos, Aurélie, Deng, Sophie X., Funderburgh, James L.
Publicado 2019

Combined Therapy Using Human Corneal Stromal Stem Cells and Quiescent Keratocytes to Prevent Corneal Scarring after Injury

por Jhanji, Vishal, Santra, Mithun, Riau, Andri K., Geary, Moira L., Yang, Tianbing, Rubin, Elizabeth, Yusoff, Nur Zahirah Binte M., Dhaliwal, Deepinder K., Mehta, Jodhbir S., Yam, Gary Hin-Fai
Publicado 2022